摘要
目的:探讨布地奈德联合特布他林雾化吸入治疗在儿童支气管哮喘急性发作中的临床效果及安全性。方法:将100例确诊为儿童支气管哮喘急性发作的患儿随机分为观察组和对照组各50例,两组均给予常规治疗,观察组加用布地奈德、特布他林雾化吸入治疗。结果:观察组在喘憋、哮鸣音、湿罗音及咳嗽的消失时间和临床控制率上与对照组比较,差异均有显著性(P<0.05),治疗期间观察组未见明显不良反应。结论:布地奈德联合特布他林雾化吸入治疗儿童支气管哮喘急性发作疗效确切、安全,是一种值得应用的临床方法。
Objective:To investigate the efficacy and safety of nebulization of budesonide combining terbutaline in the treatment of acute asthmatic attack in children.Method: One hundred patients with asthmatic attack were divided randomly into treatment and observation groups with 50 in each.Two groups received routine therapy.Nebulization of budesonide combining terbutaline was given to treatment group.Result: Significant differences in patients' therapeutic time and control rate of dyspnea,wheezing,moist rale and cough were observed in treatment as compared with observation groups(P<0.05) and no significant side effects were noted. Conclusion: It is safe and effective to treat asthmatic attack in children with nebulization of budesonide combining terbutaline in the treatment of acute asthmatic attack in children and It's worthy of clinical application.
出处
《河北医学》
CAS
2007年第3期322-324,共3页
Hebei Medicine
